What’s a Dying Man Got to Sing About?

ALS Study Finds Higher Than Usual Levels of Axon ‘Repellent’ Protein in Patients’ Motor Cortex

Motor neurodegeneration in amyotrophic lateral sclerosis (ALS) can begin in axons at neuromuscular junctions and later spread to the cell body in the spinal cord, in a phenomenon known as the “dying back” hypothesis. Proteins involved in axonal regeneration may, for this reason, represent a potential therapeutic target in ALS. A research team from Germany found…

Mark Maddox – My Story

In this video by the Motor Neurone Disease Association, meet “Mark Maddox, the soccer player who made 300 appearances for Altrincham FC and now has motor neurone disease (MND).” Learn more about ALS here: https://bit.ly/ALSNewsToday…

Biohaven’s ALS Drug Candidate BHV-0223 Receives Positive FDA Feedback

Portage Biotech and Biohaven Pharmaceuticals recently announced they have received positive feedback from the U.S. Food and Drug Administration (FDA) on their Pre-Investigational New Drug Application (PIND) interaction regarding Biohaven’s investigative drug BHV-0223, intended for treatment of amyotrophic lateral sclerosis (ALS). BHV-0223 is the glutamate modulating compound riluzole, contained in the tablet…

Living with ALS: Stories of Strength

“ALS is a fatal, neurodegenerative disease that attacks nerve cells and pathways in the brain and spinal cord and slowly robs the body of its ability to speak, swallow and breathe. In the United States, a person is diagnosed with ALS every 90 minutes. The ALS Association St. Louis…

#TBT – Living with ALS

In this 2009 WLUK-TV FOX 11 story, meet “Peggy Driessen who has ALS, or Lou Gehrig’s Disease. She gets through each day with a positive attitude — and a lot of help from loved ones.” Learn more about ALS here: https://bit.ly/ALSNewsToday…